Affymetrix signs definitive agreement to acquire eBioscience Affymetrix, Inc., today announced that it provides signed a definitive contract to acquire eBioscience, Inc., a privately-held NORTH PARK, CA-based company with an industry-leading position in flow cytometry and immunoassay reagents for oncology and immunology research and diagnostics. Under the conditions of the agreement, Affymetrix will acquire eBioscience for $330 million in cash at the mercy of certain customary changes. The transaction is at the mercy of customary closing circumstances and is expected to close past due in the fourth quarter of 2011.Leslie Ritter, Ph.D., who holds the William M. Feinberg MD Endowed Seat for Stroke Analysis at the University of Arizona, said the results of this study provides strong proof for the need to broaden both preventive and severe stroke services across the entire USA. The info emphasize the urgent have to further investigate the contribution of both traditional and non-traditional risk factors for stroke, as well as the clustering of these risk factors in every vulnerable populations, including African-People in america, Ritter said. While stable advances in regionalizing providers to diminish rural-urban disparities in stroke care have already been made in recent years, the data presented here indicate that heightened efforts in this regard are crucial clearly.